ATE430151T1 - Pyrrolopyrimidin- und pyrrolopyridin-derivate substituiert durch eine cyklische amingruppe - Google Patents

Pyrrolopyrimidin- und pyrrolopyridin-derivate substituiert durch eine cyklische amingruppe

Info

Publication number
ATE430151T1
ATE430151T1 AT06019987T AT06019987T ATE430151T1 AT E430151 T1 ATE430151 T1 AT E430151T1 AT 06019987 T AT06019987 T AT 06019987T AT 06019987 T AT06019987 T AT 06019987T AT E430151 T1 ATE430151 T1 AT E430151T1
Authority
AT
Austria
Prior art keywords
pyrrolopyrimidine
amine group
cyclic amine
derivatives substituted
pyrrolopyridine derivatives
Prior art date
Application number
AT06019987T
Other languages
English (en)
Inventor
Atsuro Nakazato
Taketoshi Okubo
Dai Nozawa
Mikako Yamaguchi
Tomoko Tamita
Ludo E J Kennis
Bruyn Marcel F L De
Jean-Pierre A M Bongartz
Den Keybus Frans M A Van
Roosbroeck Yves E M Van
Marcel G M Luyckx
Robert J M Hendrickx
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE430151T1 publication Critical patent/ATE430151T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
AT06019987T 2002-12-26 2003-12-24 Pyrrolopyrimidin- und pyrrolopyridin-derivate substituiert durch eine cyklische amingruppe ATE430151T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002383667 2002-12-26

Publications (1)

Publication Number Publication Date
ATE430151T1 true ATE430151T1 (de) 2009-05-15

Family

ID=32677471

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03768186T ATE390426T1 (de) 2002-12-26 2003-12-24 Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
AT06019987T ATE430151T1 (de) 2002-12-26 2003-12-24 Pyrrolopyrimidin- und pyrrolopyridin-derivate substituiert durch eine cyklische amingruppe

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03768186T ATE390426T1 (de) 2002-12-26 2003-12-24 Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate

Country Status (23)

Country Link
US (3) US20050209253A1 (de)
EP (2) EP1787992B1 (de)
JP (1) JP4181126B2 (de)
KR (2) KR100688395B1 (de)
CN (1) CN1692115A (de)
AR (1) AR042667A1 (de)
AT (2) ATE390426T1 (de)
AU (1) AU2003292550B8 (de)
BR (1) BR0307587A (de)
CA (1) CA2485556C (de)
CL (1) CL2003002762A1 (de)
DE (2) DE60327477D1 (de)
EA (1) EA200401060A1 (de)
ES (2) ES2302949T3 (de)
HR (1) HRP20040724A2 (de)
MX (1) MXPA04008081A (de)
MY (1) MY141200A (de)
NO (1) NO20043508L (de)
PL (1) PL371810A1 (de)
TW (1) TWI270549B (de)
UA (1) UA77265C2 (de)
WO (1) WO2004058767A1 (de)
ZA (1) ZA200405982B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4742273B2 (ja) * 2004-01-06 2011-08-10 大正製薬株式会社 ピロロピリミジン及びピロロトリアジン誘導体
EP1701961A1 (de) * 2004-01-06 2006-09-20 Taisho Pharmaceutical Co., Ltd Mit einer cyclischen aminogruppe substituierte thienopyrimidin- und thienopyridinderivate
WO2005066178A1 (en) 2004-01-06 2005-07-21 Taisho Pharmaceutical Co., Ltd. Triaza-cyclopenta[cd]indene derivatives
RU2006135120A (ru) * 2004-03-05 2008-04-10 Тайсо Фармасьютикал Ко. Производные пирролопиримидина
EP1781652A1 (de) * 2004-06-25 2007-05-09 Taisho Pharmaceutical Co., Ltd Pyrrolopyrimidin und pyrrolopyridinderivate substituiert durch tetrahydropyridin als crf-antagonisten
JP2007161585A (ja) * 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
DE102004042607A1 (de) * 2004-09-03 2006-03-09 Bayer Healthcare Ag Substituierte Phenylaminothiazole und ihre Verwendung
DE102006042143A1 (de) * 2006-09-08 2008-03-27 Bayer Healthcare Aktiengesellschaft Neue substituierte Bipyridin-Derivate und ihre Verwendung
DE102006056740A1 (de) * 2006-12-01 2008-06-05 Bayer Healthcare Ag Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
DE102006056739A1 (de) * 2006-12-01 2008-06-05 Bayer Healthcare Ag Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
DE102007035367A1 (de) 2007-07-27 2009-01-29 Bayer Healthcare Ag Substituierte Aryloxazole und ihre Verwendung
DE102007036076A1 (de) 2007-08-01 2009-02-05 Bayer Healthcare Aktiengesellschaft Dipeptoid-Produgs und ihre Verwendung
DE102007061764A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung
DE102007061763A1 (de) * 2007-12-20 2009-06-25 Bayer Healthcare Ag Substituierte azabicyclische Verbindungen und ihre Verwendung
DE102008013587A1 (de) * 2008-03-11 2009-09-17 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
AR071717A1 (es) 2008-05-13 2010-07-07 Array Biopharma Inc Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
CA2726020C (en) * 2008-05-29 2016-08-16 Bayer Schering Pharma Aktiengesellschaft 2-alkoxy-substituted dicyanopyridines and use thereof
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
DE102008062567A1 (de) 2008-12-16 2010-06-17 Bayer Schering Pharma Aktiengesellschaft Dipeptoid-Prodrugs und ihre Verwendung
DE102009006602A1 (de) * 2009-01-29 2010-08-05 Bayer Schering Pharma Aktiengesellschaft Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
DE102010030688A1 (de) 2010-06-30 2012-01-05 Bayer Schering Pharma Aktiengesellschaft Substituierte Dicyanopyridine und ihre Verwendung
US20120058983A1 (en) 2010-09-02 2012-03-08 Bayer Pharma Aktiengesellschaft Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
WO2012125746A1 (en) 2011-03-15 2012-09-20 Trius Therapeutics Inc. Tricyclic gyrase inhibitors
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015019412A8 (pt) 2013-04-11 2019-11-12 Hoffmann La Roche inibidores de bace1, seus usos, e composição farmacêutica
MX2015014081A (es) * 2013-05-02 2015-12-11 Hoffmann La Roche Derivados de pirrolo[2,3-d]pirimidina como agonistas del receptor de canabinoides 2 (cb2).
WO2021115286A1 (zh) * 2019-12-10 2021-06-17 成都倍特药业股份有限公司 一种可用作shp2抑制剂的含氮杂原子的六元并五元芳环衍生物
CN114646700B (zh) * 2022-03-01 2023-10-20 浙江国邦药业有限公司 一种（s）-吡咯烷-2-甲腈盐酸盐的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124015C1 (ru) 1992-12-17 1998-12-27 Пфайзер Инк. Производные пирроло [2,3-d] пиримидинов, фармацевтическая композиция, пирроло [2,3-d] пиримидины, производные пиррола
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
CZ287613B6 (en) 1994-06-16 2001-01-17 Pfizer Pyrazolo- and pyrrolopyridines and pharmaceutical preparations based thereon
ES2203937T3 (es) * 1997-03-26 2004-04-16 Taisho Pharmaceutical Co., Ltd Derivados de 4-tetrahidropiridilpirimidina.
CN1174984C (zh) 1999-03-11 2004-11-10 大正制药株式会社 氨基甲酰基四氢吡啶衍生物
AR028782A1 (es) * 2000-07-05 2003-05-21 Taisho Pharmaceutical Co Ltd Derivados heterociclicos tetrahidropiridino o piperidino
WO2005066178A1 (en) * 2004-01-06 2005-07-21 Taisho Pharmaceutical Co., Ltd. Triaza-cyclopenta[cd]indene derivatives

Also Published As

Publication number Publication date
EP1787992B1 (de) 2009-04-29
JP2005539090A (ja) 2005-12-22
EP1467997A1 (de) 2004-10-20
US7932259B2 (en) 2011-04-26
KR20060128063A (ko) 2006-12-13
TWI270549B (en) 2007-01-11
ZA200405982B (en) 2005-09-02
AU2003292550B2 (en) 2006-09-21
WO2004058767A1 (en) 2004-07-15
AU2003292550B8 (en) 2006-11-09
BR0307587A (pt) 2005-02-01
ATE390426T1 (de) 2008-04-15
CL2003002762A1 (es) 2005-04-08
US8455511B2 (en) 2013-06-04
PL371810A1 (en) 2005-06-27
KR100808756B1 (ko) 2008-02-29
US20050209253A1 (en) 2005-09-22
US20080287397A1 (en) 2008-11-20
EP1467997B8 (de) 2008-08-27
NO20043508L (no) 2004-10-07
KR100688395B1 (ko) 2007-03-02
ES2325596T3 (es) 2009-09-09
AU2003292550A1 (en) 2004-07-22
MY141200A (en) 2010-03-31
EP1787992A1 (de) 2007-05-23
KR20040111369A (ko) 2004-12-31
ES2302949T3 (es) 2008-08-01
DE60319951D1 (de) 2008-05-08
TW200505921A (en) 2005-02-16
AR042667A1 (es) 2005-06-29
CA2485556C (en) 2006-01-10
CA2485556A1 (en) 2004-07-15
MXPA04008081A (es) 2004-11-26
DE60327477D1 (de) 2009-06-10
DE60319951T2 (de) 2009-05-20
CN1692115A (zh) 2005-11-02
US20110130364A1 (en) 2011-06-02
EA200401060A1 (ru) 2005-02-24
HRP20040724A2 (en) 2004-10-31
EP1467997B1 (de) 2008-03-26
JP4181126B2 (ja) 2008-11-12
UA77265C2 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
ATE430151T1 (de) Pyrrolopyrimidin- und pyrrolopyridin-derivate substituiert durch eine cyklische amingruppe
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
IS7716A (is) Hringlaga heterósambönd
ATE383359T1 (de) N-aroyl zyklische amine
DK1345937T3 (da) Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
HK1139655A1 (en) Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
NO20034187D0 (no) Nye spirotricykliske derivater og anvendelse derav som fosfodiesterase-7 inhibitorer
FR14C0032I2 (fr) Pyrazolopyridines a substitution carbamate
EE200300325A (et) Asendatud amiini derivaadid ning nende kasutamismeetodid
DK1532149T3 (da) 8-[3-amino-piperiden-1-yl]-xanthiner, fremstilling deraf og anvendelse deraf som lægemiddel
NO20050830L (no) Acylerte heteroarylkondenserte sykloalkenylaminer og deres anvendelse som farmasoytiske midler
DE602004002817D1 (de) Gleichzeitige Magnetimpuls-Rahmenbildung
DE60321046D1 (de) Klettverschlüsse
NO20040877L (no) Cyklisk aminforbindelse.
ATE289626T1 (de) Viskose und amin-gehärtete dübelmasse
ATE417647T1 (de) Zahnputzformulierung in aerosolform
FR2839737B1 (fr) Poteau de cloture
DE60326420D1 (de) Kopfumschaltungsverfahren welches eine Spurnummerübereinstimmung verwendet
SE0203585L (sv) Fästelement
NO20045723D0 (no) Nitrogenholdig forbindelse, fremstilling derav og anvendelse i amino-aldehydharpikser
DE50306342D1 (de) Befestigungsmittel
DE10391559D2 (de) Gerüst
NO20030105L (no) Cyklisk substituerte aminometylforbindelser med medikamenter inneholdende den nevnte forbindelser
DE10219366B4 (de) Befestigungselement
ES1051167Y (es) Sofa perfeccionado

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties